Litcius/Paper detail

Clinical outcome of patients with relapsed refractory multiple myeloma listed for BCMA directed commercial CAR-T therapy

Samer Al Hadidi, Anikó Szabó, Jean Esselmann, Lindsay Hammons, Munawwar Hussain, Yetunde Ogunsesan, Nishanth Thalambedu, Fatima Khan, Jaskirat Sethi, Abhishek Janardan, Sabarinath Venniyil Radhakrishnan, Sharmilan Thanendrarajan, Carolina Schinke, Binod Dhakal, Siegfried Janz, Saurabh Chhabra, Anita D’Souza, Maurizio Zangari, Frits van Rhee, Meera Mohan

2022Bone Marrow Transplantation22 citationsDOI

Topics & Concepts

MedicineMultiple myelomaRefractory (planetary science)OncologyInternal medicineOutcome (game theory)SurgeryMathematicsAstrobiologyMathematical economicsPhysicsMultiple Myeloma Research and TreatmentsCAR-T cell therapy researchProtein Degradation and Inhibitors
Clinical outcome of patients with relapsed refractory multiple myeloma listed for BCMA directed commercial CAR-T therapy | Litcius